Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03643796 · ClinicalTrials.gov registry record · Phase 4
Narcotic Free TIVA and Incidence of Unacceptable Movements Under Anesthesia During ACDF Surgery
A Phase 4 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Phase 4
- Development phase
- 32
- Enrollment target
NCT03643796 is a Phase 4 study that has completed, run by University of Arkansas. The registered enrollment target is 32 participants.
The verdict
NCT03643796, a Phase 4 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study will help the investigators learn more about the best way to give anesthesia for these kinds of surgery. The investigators will be using 2 different groups of medications that is commonly used in ACDF surgery, one group has a Narcotic, and the other group does not. The investigators wish to test whether a narcotic free anesthetic will result in an overall safer surgery, better patient recovery, and satisfaction. The investigators think also that eliminating the Narcotic from the Anesthetic regimen will allow patients to recover faster after surgery , and consume less pain medicines in the postoperative period.
Interventions
- DRUG Ketamine
- DRUG Dexmedetomidine
- DRUG Remifentanil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-07-15 |
| Est. Completion | 2022-07-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03643796
The ClinicalTrials.gov registry entry for NCT03643796 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ketamine is the first listed.
NCT03643796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03643796 about?
NCT03643796 is a clinical study titled "Narcotic Free TIVA and Incidence of Unacceptable Movements Under Anesthesia During ACDF Surgery". This study will help the investigators learn more about the best way to give anesthesia for these kinds of surgery. The investigators will be using 2 different groups of medications that is commonly used in ACDF surgery, one group has a Narcotic, and the other group does not. The investigators wish ...
What is the current status of trial NCT03643796?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 32 participants. The study started on 2018-07-15. Estimated completion is 2022-07-05.
What interventions are being tested in trial NCT03643796?
The interventions under investigation include: Ketamine (DRUG), Dexmedetomidine (DRUG), Remifentanil (DRUG).
Who is sponsoring clinical trial NCT03643796?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.